c.kuusela
TL2 · Gdańsk
Contributes reviews on supplier material. Based in Gdańsk.
Joined 17 October 2024 · last posted 16h
78 posts, newest first. Showing up to 150.
-
GIP receptor agonism and the argument about direction — does this still hold? Replied, post #15 · Pharmacology › Receptor biology · 27 Jul 2026 · 0 likes Good question, well framed, and I would like to see it answered properly.
-
Coming back to: Preparing for an appointment: one page, three questions Replied, post #43 · Clinical › Prescriber conversations · 24 Jul 2026 · 4 likes Bringing a record of symptoms with dates and severities makes an assessment materially easier and is the single most useful preparation. Same conclusion as the reply…
-
Search filters: what is missing Replied, post #84 · Meta › Site feedback · 23 Jul 2026 · 9 likes This follows post #81 rather than contradicting it. Guideline clarity: if the guidelines are unclear or seem to be applied inconsistently, post the specific situation…
-
Revisiting: What pooling buys you and what it destroys Replied, post #99 · Evidence › Meta-analyses · 20 Jul 2026 · 15 likes Study quality and weighting: some meta-analyses weight all studies equally; others weight by study size or study quality. The choice affects the result and should be…
-
Documenting a supplier's response to a discrepancy Replied, post #40 · Sourcing › Vendor reports · 16 Jul 2026 · 0 likes Taking post #37 at face value and following it one step further. If the supplier was asked about a discrepancy, include what they said verbatim rather than summarised.…
-
Trust level 3 requirements: a clarification — does this still hold? Replied, post #74 · Meta › Announcements · 30 Jun 2026 · 24 likes One question about the transition rather than the policy: what happens to topics that are in flight when it takes effect? The announcement is clear about posts and…
-
How shortages have affected compounding permissions Replied, post #3 · Access › Shortages · 28 Jun 2026 · 0 likes Allocation and rationing: during severe shortages, suppliers might ration allocation to prescribers. Understanding rationing policies from your prescriber matters for…
-
Personal or family history of medullary thyroid carcinoma Replied, post #20 · Safety › Contraindications · 27 Jun 2026 · 4 likes Post #17 and I disagree about the size of the effect, not about the direction. Somebody's condition being on a list does not settle the decision, and somebody's…
-
Journal club: STEP 1 and the treatment-policy estimand — does this still hold? Replied, post #41 · Evidence › Journal club · 13 Jun 2026 · 14 likes The figures usually contain the finding and the text usually contains the interpretation. Separating them for the first twenty minutes is a discipline worth keeping.…
-
Official shortage notices and what they authorise Replied, post #94 · Access › Shortages · 8 Jun 2026 · 0 likes Taking post #93 at face value and following it one step further. Manufacturer allocation decisions during a shortage are commercial and are rarely explained, which is…
-
An appeal that succeeded, with the letter structure — the long version Replied, post #66 · Access › Insurance & coverage · 7 Jun 2026 · 1 like This follows post #63 rather than contradicting it. Denial letters: the stated reason tells you exactly what to submit next. A denial is not final; it is a…
-
How to ask a question when you cannot say why you are asking it Replied, post #8 · Start Here › How to Ask · 7 Jun 2026 · 1 like Units. Everything needs units. This is why we ask every single time. I have seen the same arithmetic done three different ways depending on whether the person was…
-
Second pass at: Sleep apnoea improving and the equipment implications Replied, post #53 · Wellbeing › Sleep · 7 Jun 2026 · 2 likes The published data on sleep outcomes in this class is thinner than the volume of discussion, which is worth saying plainly. This has been discussed before and I could…
-
Official shortage notices and what they authorise Replied, post #77 · Access › Shortages · 30 May 2026 · 0 likes Marking my place. If it changes for me I will come back and say so.
-
What a certificate commits its issuer to — one year on Replied, post #78 · Analytics › COA interpretation · 30 May 2026 · 7 likes Taking post #75 at face value and following it one step further. The signature block matters more than it appears to. A named individual with a date is a different kind…
-
Follow-up: Sleep quality changes during weight loss Replied, post #23 · Wellbeing › Sleep · 16 May 2026 · 0 likes Thank you for taking the time. That was more work than a reply usually is.
-
GLP-1 receptor distribution: central and peripheral Replied, post #48 · Pharmacology › Receptor biology · 12 May 2026 · 15 likes Receptor desensitisation and internalisation are real phenomena in vitro and their clinical relevance to these compounds is not established. That distinction gets lost…
-
The 2.5 mg starting dose is not a therapeutic dose — why that matters Replied, post #120 · Compounds › Tirzepatide · 12 May 2026 · 0 likes I keep a log for 2.5 mg starting dose specifically because my memory of it turned out to be systematically wrong in one direction. Six weeks of notes cost nothing and…
-
How this community labels and discusses unrefereed work — the long version Replied, post #10 · Evidence › Preprints · 11 May 2026 · 9 likes Check whether it was later published: searching for the preprint's first author and keywords in PubMed might find a published version. The published version is the…
-
[2026 update] Area percent versus weight percent: the confusion that causes most arguments Replied, post #40 · Analytics › HPLC & UHPLC · 7 May 2026 · 21 likes Post #37 answers the question as asked. The question underneath it is different. A definition problem is doing most of the work in this Area percent versus weight…
-
[2026 update] 0.3 mL versus 0.5 mL versus 1 mL barrels: resolution matters Replied, post #91 · Devices › Syringes & needles · 5 May 2026 · 1 like Worth separating two things that post #88 runs together. If someone has run 0.3 ml versus 0.5 ml properly I would rather read that than my own reconstruction of it.…
-
[2026 update] 0.3 mL versus 0.5 mL versus 1 mL barrels: resolution matters Replied, post #72 · Devices › Syringes & needles · 29 Apr 2026 · 1 like Confirming post #70 from a second method, which matters more than confirming it from a second person. U-100 means the barrel is graduated for a solution containing one…
-
Follow-up: Comparing two chromatograms from different laboratories, properly Replied, post #17 · Analytics › HPLC & UHPLC · 24 Apr 2026 · 29 likes Acknowledging rather than arguing. The reasoning holds as far as I can follow it.
-
The 2.5 mg starting dose is not a therapeutic dose — why that matters Replied, post #91 · Compounds › Tirzepatide · 21 Apr 2026 · 22 likes The arithmetic in post #90 is right; the assumption feeding it is the part to check. The published pharmacokinetics show dose proportionality across the studied range,…
-
Amylin receptor signalling and satiety — what changed since Replied, post #55 · Pharmacology › Receptor biology · 2 Apr 2026 · 0 likes Post #52 put the caveat in the right place and I want to underline it. GIP receptor signalling: the glucose-dependent insulinotropic peptide receptor (GIP) is involved…
-
Adducts: sodium, potassium, and the peak you did not expect — does this still hold? Replied, post #80 · Analytics › Mass spectrometry · 23 Mar 2026 · 8 likes Confirming post #77 from a second method, which matters more than confirming it from a second person. Adducts has a well-known answer and a correct answer, and the…
-
Micro-titration: a disputed topic, argued properly Replied, post #48 · Practice › Dosing & titration · 19 Mar 2026 · 31 likes Concentration and dose get conflated constantly in this subcategory. Changing how much diluent you add changes the volume you draw and changes nothing about the dose.…
-
Nausea profile of amylin analogues compared with GLP-1 agonists Replied, post #75 · Compounds › Cagrilintide & amylin analogues · 18 Mar 2026 · 29 likes Nausea profile of amylin analogues is one of those subjects where the general answer and the answer for a specific case diverge, and the thread will go in circles until…
-
About the Sleep category Replied, post #4 · Wellbeing › Sleep · 17 Mar 2026 · 7 likes Suggestion for the wiki post above: it would be worth linking the two or three most-referenced topics in this category directly, since new members reliably ask for…
-
Revisiting: Absolute versus relative contraindications Replied, post #45 · Safety › Contraindications · 16 Mar 2026 · 4 likes Gastroparesis or severe delayed gastric emptying: these compounds slow gastric emptying. Pre-existing severe gastroparesis can be worsened. That is a relative…
-
Second pass at: Where impurities in solid-phase peptide synthesis come from Replied, post #49 · Analytics › Impurities & related substances · 26 Feb 2026 · 4 likes The arithmetic on impurities in solid-phase peptide synthesis is the easy part and it is where the errors are, which is an uncomfortable combination. Show your working…
-
Follow-up: Search filters: what is missing Replied, post #28 · Meta › Site feedback · 6 Feb 2026 · 3 likes Post #26 describes the usual case. This is about the unusual one. Display issues: broken layouts, images not loading, text overlapping — report with the browser and…
-
Second pass at: Circumference measurements as a poor man's composition estimate Replied, post #49 · Outcomes › Body composition · 4 Feb 2026 · 0 likes My position on Circumference measurements is current rather than settled. I have revised it once already and I expect to again, so treat it accordingly.
-
Filter needles: when they help and what they cost you Replied, post #38 · Devices › Syringes & needles · 29 Jan 2026 · 5 likes Two claims get bundled together under filter needles and they need separating. The descriptive one — this is what was observed — is usually well supported. The causal…
-
Coverage in the US: a map of the usual obstacles Replied, post #34 · Regional › North America · 10 Jan 2026 · 8 likes Taking coverage seriously for a moment rather than deflecting: the honest position is that the community has observations and no controlled comparison, and those two…
-
Half-life, steady state, and accumulation worked through — a second dataset Replied, post #52 · Pharmacology › Pharmacokinetics · 4 Jan 2026 · 0 likes Metabolism for peptide drugs is proteolytic rather than hepatic in the usual sense, which is why the cytochrome interaction questions that dominate small-molecule…
-
How to tell whether your question is already answered on a maintained page Replied, post #5 · Start Here › Welcome · 29 Dec 2025 · 2 likes Marked solutions are the site's way of saying that someone asked a good question and someone else gave an answer that actually worked. It is not a competition and it…
-
The decimal-point error, and the habit that catches it Replied, post #26 · Practice › Reconstitution · 14 Dec 2025 · 1 like Taking post #25 at face value and following it one step further. A note on how decimal-point error gets discussed rather than on decimal-point error itself: the…
-
Tirzepatide in type 2 diabetes: the SURPASS programme, summarised honestly — the long… Replied, post #37 · Compounds › Tirzepatide · 5 Dec 2025 · 0 likes Helpful, and short, which on this subject is harder than long.
-
Warfarin and altered intake: the monitoring argument — the long version Replied, post #42 · Practice › Interactions · 1 Nov 2025 · 3 likes Insulin interaction: semaglutide and tirzepatide are not contraindicated with insulin but the combination carries hypoglycemia risk if insulin doses are not adjusted.…
-
Titles that describe the question, not the situation Replied, post #114 · Start Here › How to Ask · 6 Oct 2025 · 11 likes The specific question in the title is more useful than you might think. A title like "a question I have" forces the person answering to guess what you want to know. A…
-
Citing a preprint in a maintained document: our rule and its reasoning — does this still… Replied, post #60 · Evidence › Preprints · 30 Sep 2025 · 21 likes One caution on Citing a preprint: everything above assumes the underlying documentation is what it claims to be. That assumption is doing real work and is rarely stated.
-
An inter-laboratory comparison on one lot, tabulated — what changed since Replied, post #3 · Analytics › Method validation · 30 Sep 2025 · 0 likes The arithmetic on inter-laboratory comparison is the easy part and it is where the errors are, which is an uncomfortable combination. Show your working and someone will…
-
Revisiting: Reading a denial letter as a specification for your appeal Replied, post #133 · Access › Insurance & coverage · 24 Sep 2025 · 0 likes Post #130 answers the question as asked. The question underneath it is different. One caution on Reading a denial letter: everything above assumes the underlying…
-
Request: a diff view for wiki revisions — the long version Replied, post #40 · Meta › Feature requests · 8 Sep 2025 · 0 likes On diff view for wiki revisions, I would rather understate and be corrected upward than overstate and be quoted. That is a house style here and it is a good one.
-
Semaglutide versus liraglutide head to head: reading STEP 8 carefully Replied, post #44 · Compounds › Semaglutide · 19 Aug 2025 · 32 likes Gastric emptying delay is the mechanism behind most of the gastrointestinal side effects. Slowing the stomach empties it feeds less food into the intestines at a time,…
-
The "under review" status pill and when a moderator applies it — a second dataset Replied, post #25 · Evidence › Preprints · 18 Aug 2025 · 0 likes Say it is a preprint in the first line rather than the last. Everything downstream depends on that status and readers arriving from search will not scroll for it.
-
A request that was declined, and the reasoning — a second dataset Replied, post #98 · Documentation › Wiki requests · 15 Aug 2025 · 10 likes Accessibility feedback: if you have trouble accessing or reading a maintained page (screen reader issues, contrast problems, small text) report it. Accessibility…
-
Tracking that stops updating and then resumes — the long version Replied, post #5 · Sourcing › Logistics · 13 Aug 2025 · 0 likes Post #3 put the caveat in the right place and I want to underline it. Split shipments reduce single-point risk and increase the number of transits. Which trade is right…
-
The nausea timeline across the first four weeks, with a tabulated log — what changed since Replied, post #4 · Practice › Side effects · 13 Aug 2025 · 0 likes What I want from this nausea timeline thread is the list of things that would need to be true for the claim to hold. If we can write that list, we can check it.
-
Second pass at: Semaglutide and alcohol: what is actually documented Replied, post #19 · Compounds › Semaglutide · 27 Jun 2025 · 1 like Semaglutide versus liraglutide in STEP 8: semaglutide produced greater weight reduction and the discontinuation rates differed. But the trial was open-label for the…
-
[2026 update] An appeal that failed, and what I would do differently Replied, post #44 · Access › Insurance & coverage · 9 Jun 2025 · 10 likes Post #43 and I disagree about the size of the effect, not about the direction. Worth separating appeal as a question about the compound from appeal as a question about…
-
Obstructive sleep apnoea and a hard endpoint in this class Replied, post #101 · Clinical › Comorbidities · 1 Jun 2025 · 30 likes Comorbidity control: if a comorbidity (high blood pressure, high lipids) is not adequately controlled, the decision about adding compounds in this class depends on the…
-
Telehealth prescribing models in the US Replied, post #103 · Regional › North America · 24 May 2025 · 5 likes Pharmacy practice varies between pharmacies within the same city, so two honest accounts can be entirely different. I am describing what is, rather than arguing for…
-
What SELECT changed about how semaglutide is discussed, and what it did not Replied, post #122 · Compounds › Semaglutide · 17 May 2025 · 0 likes I would call the community position on SELECT likely rather than established, and I would be comfortable defending that hedge.
-
Follow-up: Open-label extensions: what survives and what does not Replied, post #22 · Evidence › Trials · 30 Mar 2025 · 10 likes Bookmarking this. I will come back when I have something worth adding.
-
Reading an MS report that only gives you a single number Replied, post #36 · Analytics › Mass spectrometry · 24 Mar 2025 · 0 likes Resolution: "high resolution" commonly means Worth one more sentence than it usually gets.
-
Maintainer handover: how it works Replied, post #62 · Meta › Wiki maintenance · 18 Mar 2025 · 1 like Second-hand on maintainer handover, so weight it accordingly — someone whose method I trust told me this and I have not verified it myself.
-
Biased agonism: a real phenomenon, an over-used explanation — what changed since Replied, post #41 · Pharmacology › Receptor biology · 2 Feb 2025 · 14 likes Central versus peripheral action: GLP-1 agonism works through both central nervous system effects (appetite) and peripheral effects (gastric motility, insulin). The…
-
Distinguishing a deletion sequence by mass alone Replied, post #25 · Analytics › Mass spectrometry · 28 Jan 2025 · 6 likes Combining a chromatographic result with a mass result is genuinely orthogonal confirmation. Either alone leaves a specific class of problem invisible, and the two…
-
Revisiting: Holding a dose indefinitely: is there a documented downside? Replied, post #30 · Practice › Dosing & titration · 24 Jan 2025 · 6 likes This follows post #27 rather than contradicting it. Holding a dose is well covered in the tag pages, and the older discussions are better than the recent ones because…
-
Feature request: should a dose-equivalence tool exist at all? Replied, post #16 · Data & Tools › Calculators · 20 Jan 2025 · 31 likes Confirming post #13 from a second method, which matters more than confirming it from a second person. Mass error checking: enter your observed mass and theoretical mass…
-
Coming back to: Renal impairment: what the labelling says about dose Replied, post #30 · Clinical › Special populations · 19 Jan 2025 · 22 likes The arithmetic in post #27 is right; the assumption feeding it is the part to check. Worth separating Renal impairment as a question about the compound from Renal…
-
Recovery when intake is low: what to cut first Replied, post #57 · Nutrition & Training › Resistance training · 13 Jan 2025 · 10 likes Building on post #54 rather than restating it. The reports here that state the programme, the load and the timeframe are useful. The ones that state an outcome are not.…
-
Revisiting: Bug report: the reconstitution calculator and a rounding edge case Replied, post #47 · Data & Tools › Calculators · 10 Jan 2025 · 2 likes Why calculators are not medical advice: they do arithmetic. Medical decisions are not arithmetic. A calculator that says a certain dose is "compatible with" a certain…
-
The report format the maintainers ask for, and why each field is there — what changed… Replied, post #4 · Sourcing › Vendor reports · 8 Jan 2025 · 0 likes Comparing your result to somebody else's on a different lot is not a comparison of suppliers. Lot is the unit and it should be in every report.
-
Books and papers worth reading that are not about this at all Replied, post #4 · Lounge › Off topic · 30 Dec 2024 · 14 likes This settles it for me, at least until somebody posts a reason it should not.
-
Second pass at: Pharmacy supply in the UK and the questions you will be asked Replied, post #6 · Regional › UK & Ireland · 22 Dec 2024 · 4 likes Post #5 answers the question as asked. The question underneath it is different. I read the earlier replies on Pharmacy supply twice before writing this, because I had…
-
About the Wiki requests category Replied, post #4 · Documentation › Wiki requests · 16 Dec 2024 · 2 likes Suggestion for the wiki post above: it would be worth linking the two or three most-referenced topics in this category directly, since new members reliably ask for…
-
Second pass at: Regression to the mean in progress reports Replied, post #2 · Research Methods › Statistics · 15 Dec 2024 · 0 likes Right, and stated more narrowly than I would have dared to state it.
-
Reading a preclinical wound-healing model and its relevance to a human tendon Replied, post #78 · Compounds › Repair & healing peptides · 17 Nov 2024 · 0 likes The pentadecapeptide sequence is short and stable enough to survive conditions that would degrade a larger peptide, which is one of the few things about it that is well…
-
EMA product information as a primary source — does this still hold? Replied, post #9 · Regional › European Union · 14 Nov 2024 · 9 likes On EMA product information, I would rather understate and be corrected upward than overstate and be quoted. That is a house style here and it is a good one.
-
People with a low starting BMI: where the evidence stops Replied, post #9 · Clinical › Special populations · 20 Oct 2024 · 0 likes Adding a note of thanks rather than an opinion. I did not know most of that.
-
Progressive overload when the scale is falling — one year on Replied, post #87 · Nutrition & Training › Resistance training · 24 Sep 2024 · 18 likes Post #83 describes the usual case. This is about the unusual one. On Progressive overload, I would rather understate and be corrected upward than overstate and be…
-
Transit times by route, from a logged dataset — the long version Replied, post #6 · Sourcing › Logistics · 18 Aug 2024 · 3 likes On Transit times, I would rather understate and be corrected upward than overstate and be quoted. That is a house style here and it is a good one.
-
Revisiting: US compounding rules and how they changed Replied, post #2 · Regional › North America · 5 Aug 2024 · 0 likes Cross-border purchase: buying in the US and bringing to Canada or vice versa involves both countries' import rules. The medication is legal but crossing borders with it…
-
Identical chromatograms across two different lots Replied, post #11 · Sourcing › Red flags · 2 Aug 2024 · 21 likes Post #9 is right about the mechanism and I think understates the practical bit. The strongest single signal available cheaply is what happens when you ask a technical…
-
How this community labels and discusses unrefereed work Replied, post #119 · Evidence › Preprints · 28 Jul 2024 · 4 likes Counterpoint on community labels, offered without confidence: the same observation is consistent with a much duller explanation, and nobody has ruled the dull one out.